Blog Posts - Technivie



AbbVie's TECHNIVIE™ Receives Health Canada Approval for Genotype 4 Chronic Hepatitis C Infection

AbbVie's TECHNIVIE™ Receives Health Canada Approval for Genotype 4 Chronic Hepatitis C Infection TECHNIVIE provides an opportunity to treat adults who have genotype 4 (GT4) chronic hepatitis C virus... Monday HCV News Ticker- Hepatitis C: Coffee,...
by HCV New Drug Research on Nov 24, 2015

Hepatitis C Drugs Viekira Pak And Technivie Require Warnings Label Changes Due To Liver Injury Reports

FDA Says The Timing Of Liver Injury Suggests That These Are Side Effects, Especially In Patients With Advanced Cirrhosis (Posted by Tom Lamb at DrugInjuryWatch.com) Viekira Pak and Technivie are relatively new drugs used to treat chronic hepatitis C.
by Drug Injury Watch on Oct 26, 2015

Viekira Pak and Technivie - FDA warns of serious liver injury risk with hepatitis C treatments

AbbVie's Hepatitis C Drugs Label Changed After Patient Deaths Seven patients on AbbVie Inc.’s drugs for hepatitis C died after liver failure, prompting U.S. regulators to change their advice on how... Monday HCV News Ticker- Hepatitis C: Coffee, M...
by HCV New Drug Research on Oct 22, 2015

August Newsletters: The Cure for Gilead, New drugs, Genotypes, Plus Hepatitis C and Nonalcoholic Fatty Liver Disease

August Newsletters: New HCV Drugs, Genotypes, Plus Hepatitis C and Nonalcoholic Fatty Liver Disease  Welcome to this months index of August "Newsletters" with a few updates from around the... Monday HCV News Ticker- Hepatitis C: Coffee, Medicar...
by HCV New Drug Research on Aug 2, 2015

August Newsletters: New HCV Drugs, Genotypes, Plus Hepatitis C and Nonalcoholic Fatty Liver Disease

August Newsletters: New HCV Drugs, Genotypes, Plus Hepatitis C and Nonalcoholic Fatty Liver Disease  Welcome to this months index of August "Newsletters" with a few updates from around the... Monday HCV News Ticker- Hepatitis C: Coffee, Medica...
by HCV New Drug Research on Aug 2, 2015

FDA Hepatitis Update - Approval of AbbVie's Technivie (ombitasvir, paritaprevir, ritonavir) w-ribavirin to treat HCV genotype 4

FDA Hepatitis Update - Approval of Technivie to treat of genotype 4 chronic hepatitis C virus‏ On July 24, 2015, FDA approved TECHNIVIE, a fixed-dose combination containing ombitasvir, a hepatitis C... Monday HCV News Ticker- Hepatitis C: Coffee,...
by HCV New Drug Research on Jul 24, 2015


Trending Topics

Close